January 10th, 2015

Protein Alternatives’ project proposal named ‘ColoDetect – Development of a novel blood-based diagnostic test for colorectal cancer’ has been selected to receive funding from the EU Framework Programme Horizon 2020 SME Instrument. The official communication was received by the company in December and the firm is negotiating the grant conditions at the present, with the focus on starting the project activities in April.